Bioventus Market Cap

Bioventus has a market cap or net worth of $408.50 million as of May 17, 2024. Its market cap has increased by 332.73% in one year.

Market Cap

408.50M

Enterprise Value

774.56M

1-Year Change

332.73%

Ranking

#3140

Market Cap Chart

Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $408.50M, a decrease of -42.74%. That is a compound annual growth rate of -15.71%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	507.90M	-3.77%
May 16, 2024	527.80M	4.39%
May 15, 2024	505.60M	6.02%
May 14, 2024	476.90M	4.72%
May 13, 2024	455.40M	5.93%
May 10, 2024	429.90M	-1.10%
May 9, 2024	434.70M	8.32%
May 8, 2024	401.30M	-1.55%
May 7, 2024	407.60M	28.70%
May 6, 2024	316.70M	0.76%
May 3, 2024	314.30M	0.26%
May 2, 2024	313.50M	-0.76%
May 1, 2024	315.90M	0.77%
Apr 30, 2024	313.50M	-2.70%
Apr 29, 2024	322.20M	2.25%
Apr 26, 2024	315.10M	-2.20%
Apr 25, 2024	322.20M	-1.92%
Apr 24, 2024	328.50M	-3.72%
Apr 23, 2024	341.20M	0.47%
Apr 22, 2024	339.60M	-4.26%
Apr 19, 2024	354.70M	-1.53%
Apr 18, 2024	360.20M	-3.20%
Apr 17, 2024	372.10M	1.31%
Apr 16, 2024	367.30M	0.22%
Apr 15, 2024	366.50M	1.30%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Neurogene	428.54M
LENZ Therapeutics	416.71M
Nevro	416.32M
Enhabit	413.38M
Health Catalyst	410.29M
ADC Therapeutics	401.74M
Esperion Therapeutics	399.63M
Annexon	396.47M

Market Cap Rankings